Page last updated: 2024-09-04

bdp 12 and Schizophrenia

bdp 12 has been researched along with Schizophrenia in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (88.89)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Broberg, BV; Dias, R; Glenthøj, BY; Larsen, DB; Olsen, CK	1
Begemann, MJ; Leucht, S; Sommer, IE; Temmerman, A	1
Danysz, W	1
Egan, MF; Goldberg, TE; Knable, MB; Marenco, S; McClure, RK; Weinberger, DR; Winterer, G	1
Ballew, N	1
Tiihonen, J; Tuominen, HJ; Wahlbeck, K	1
Black, MD	1
Freudenreich, O; Goff, DC; Green, MF; Johnson, SA; Lamberti, JS; Leon, AC; Manschreck, T; Miller, AL; Patel, J	1
Berman, I; Goff, DC; Herz, L; Johnson, SA; Leahy, L; Leon, AC; Lynch, G; Posever, T	1

Reviews

4 review(s) available for bdp 12 and Schizophrenia

Article	Year
Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review. Schizophrenia bulletin, 2012, Volume: 38, Issue:5 Topics: Antipsychotic Agents; Brief Psychiatric Rating Scale; Citalopram; Clozapine; Dioxoles; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fructose; Humans; Lamotrigine; Piperidines; Psychiatric Status Rating Scales; Psychotropic Drugs; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Sulpiride; Topiramate; Treatment Outcome; Triazines	2012
Positive modulators of AMPA receptors as a potential treatment for schizophrenia. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:7 Topics: Animals; Clinical Trials as Topic; Dioxoles; Drug Industry; Excitatory Amino Acid Agonists; Humans; Piperidines; Receptors, AMPA; Schizophrenia	2002
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophrenia research, 2005, Jan-01, Volume: 72, Issue:2-3 Topics: Clozapine; Cycloserine; Dioxoles; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Agents; Glycine; Humans; Hydro-Lyases; Molindone; Piperidines; Schizophrenia	2005
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data. Psychopharmacology, 2005, Volume: 179, Issue:1 Topics: Alzheimer Disease; Animals; Benzothiadiazines; Cognition; Dioxoles; Humans; Long-Term Potentiation; Memory; Neuroprotective Agents; Piperidines; Protein Subunits; Receptors, AMPA; Schizophrenia	2005

Trials

3 trial(s) available for bdp 12 and Schizophrenia

Article	Year
Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series. Schizophrenia research, 2002, Oct-01, Volume: 57, Issue:2-3 Topics: Adult; Antipsychotic Agents; Dioxoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperidines; Psychotic Disorders; Schizophrenia	2002
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dioxoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Pilot Projects; Piperidines; Psychiatric Status Rating Scales; Psychomotor Performance; Risperidone; Sample Size; Schizophrenia; Schizophrenic Psychology	2008
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:5 Topics: Adult; Antipsychotic Agents; Attention; Clozapine; Cognition; Dioxoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memory; Middle Aged; Pilot Projects; Piperidines; Psychological Tests; Schizophrenia	2001

Other Studies

2 other study(ies) available for bdp 12 and Schizophrenia

Article	Year
Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting. Psychopharmacology, 2009, Volume: 206, Issue:4 Topics: Animals; Antipsychotic Agents; Attention; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Indoles; Male; Phencyclidine; Piperidines; Rats; Schizophrenia	2009
Cortex Pharmaceuticals, Inc. Maintaining brain function goes a long way. Chemistry & biology, 2003, Volume: 10, Issue:11 Topics: Animals; Brain; Cognition Disorders; Dioxoles; Drug Industry; Humans; Piperidines; Receptors, AMPA; Schizophrenia	2003

Article

Year

Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting.

Psychopharmacology, 2009, Volume: 206, Issue:4

Topics: Animals; Antipsychotic Agents; Attention; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Indoles; Male; Phencyclidine; Piperidines; Rats; Schizophrenia

2009

Cortex Pharmaceuticals, Inc. Maintaining brain function goes a long way.

Chemistry & biology, 2003, Volume: 10, Issue:11

Topics: Animals; Brain; Cognition Disorders; Dioxoles; Drug Industry; Humans; Piperidines; Receptors, AMPA; Schizophrenia

2003